10-Q Filing

ABBVIE INC. CIK: 1551152 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001551152-22-000030`
Period End Date	20220630
Filing Date	20220804
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	abbv-20220630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 80 Cash Flow Statement 79 Stockholders Equity 36 Comprehensive Income 52

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	4.00B	shares	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	4.00B	shares	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	1.80B	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.75B	USD	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	1.81B	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.52B	USD	Point-in-time
Common stock held in treasury, at cost (in shares)	`TreasuryStockShares`	44.60M	shares	Point-in-time
Common stock held in treasury, at cost (in shares)	`TreasuryStockShares`	34.86M	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$84.00M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$1.44B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$9.98B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$11.24B	USD	Point-in-time
Inventories	`InventoryNet`	$3.40B	USD	Point-in-time
Inventories	`InventoryNet`	$3.13B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssets`	$4.99B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssets`	$4.51B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$29.10B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$27.93B	USD	Point-in-time
Investments	`LongTermInvestments`	$277.00M	USD	Point-in-time
Investments	`LongTermInvestments`	$244.00M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.96B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.11B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$75.95B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$71.82B	USD	Point-in-time
Goodwill	`Goodwill`	$32.03B	USD	Point-in-time
Goodwill	`Goodwill`	$32.38B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.88B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$5.03B	USD	Point-in-time
Total assets	`Assets`	$146.53B	USD	Point-in-time
Total assets	`Assets`	$143.19B	USD	Point-in-time
Short-term borrowings	`ShortTermBorrowings`	$14.00M	USD	Point-in-time
Short-term borrowings	`ShortTermBorrowings`	$17.00M	USD	Point-in-time
Current portion of long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$12.48B	USD	Point-in-time
Current portion of long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$11.91B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$22.54B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$22.70B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$34.47B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$35.19B	USD	Point-in-time
Long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligations`	$64.19B	USD	Point-in-time
Long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligations`	$61.00B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$2.25B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.01B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$30.77B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$28.70B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,812,622,099 shares issued as of June 30, 2022 and 1,803,195,293 as of December 31, 2021	`CommonStockValueOutstanding`	$18.00M	USD	Point-in-time
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,812,622,099 shares issued as of June 30, 2022 and 1,803,195,293 as of December 31, 2021	`CommonStockValueOutstanding`	$18.00M	USD	Point-in-time
Common stock held in treasury, at cost, 44,595,448 shares as of June 30, 2022 and 34,857,597 as of December 31, 2021	`TreasuryStockValue`	$3.14B	USD	Point-in-time
Common stock held in treasury, at cost, 44,595,448 shares as of June 30, 2022 and 34,857,597 as of December 31, 2021	`TreasuryStockValue`	$4.59B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$18.30B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$18.91B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.13B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.52B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.90B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.20B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.41B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.65B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$35.00M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$28.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.10B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.73B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.69B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.59B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.44B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.31B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$143.19B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$146.53B	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$26.97B	USD	2 Qtrs
Net revenues	`Revenues`	$13.96B	USD	1 Quarter
Net revenues	`Revenues`	$14.58B	USD	1 Quarter
Net revenues	`Revenues`	$28.12B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$4.52B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$4.17B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$8.74B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$8.22B	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$5.41B	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.16B	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$8.54B	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$6.01B	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.77B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$3.11B	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$3.43B	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.61B	USD	1 Quarter
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$317.00M	USD	2 Qtrs
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$269.00M	USD	1 Quarter
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$414.00M	USD	2 Qtrs
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$132.00M	USD	1 Quarter
Other operating income	`OtherOperatingIncomeExpenseNet`	$172.00M	USD	1 Quarter
Other operating income	`OtherOperatingIncomeExpenseNet`	$68.00M	USD	1 Quarter
Other operating income	`OtherOperatingIncomeExpenseNet`	$68.00M	USD	2 Qtrs
Other operating income	`OtherOperatingIncomeExpenseNet`	$172.00M	USD	2 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$9.52B	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$11.29B	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$20.11B	USD	2 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$18.43B	USD	2 Qtrs
Operating earnings	`OperatingIncomeLoss`	$3.29B	USD	1 Quarter
Operating earnings	`OperatingIncomeLoss`	$8.01B	USD	2 Qtrs
Operating earnings	`OperatingIncomeLoss`	$8.54B	USD	2 Qtrs
Operating earnings	`OperatingIncomeLoss`	$4.44B	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-1.07B	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-1.23B	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-532.00M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-606.00M	USD	1 Quarter
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-23.00M	USD	2 Qtrs
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-72.00M	USD	2 Qtrs
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-47.00M	USD	1 Quarter
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-14.00M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-1.53B	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-2.26B	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-2.66B	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-757.00M	USD	2 Qtrs
Earnings before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.16B	USD	1 Quarter
Earnings before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.18B	USD	1 Quarter
Earnings before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.03B	USD	2 Qtrs
Earnings before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$6.11B	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$706.00M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$255.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$691.00M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$394.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$769.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$928.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$5.42B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$4.32B	USD	2 Qtrs
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.00M	USD	2 Qtrs
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$7.00M	USD	2 Qtrs
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$4.00M	USD	1 Quarter
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$3.00M	USD	1 Quarter
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$924.00M	USD	1 Quarter
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$766.00M	USD	1 Quarter
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$4.32B	USD	2 Qtrs
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$5.41B	USD	2 Qtrs
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$0.42	USD	1 Quarter
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$0.52	USD	1 Quarter
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$3.04	USD	2 Qtrs
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$2.42	USD	2 Qtrs
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$3.03	USD	2 Qtrs
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$0.42	USD	1 Quarter
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$0.51	USD	1 Quarter
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$2.41	USD	2 Qtrs
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.77B	shares	2 Qtrs
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.77B	shares	1 Quarter
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.77B	shares	1 Quarter
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.77B	shares	2 Qtrs
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.78B	shares	1 Quarter
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.78B	shares	2 Qtrs
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.78B	shares	1 Quarter
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.78B	shares	2 Qtrs

Cash Flow Statement 79 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$769.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$928.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$5.42B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$4.32B	USD	2 Qtrs
Depreciation	`Depreciation`	$401.00M	USD	2 Qtrs
Depreciation	`Depreciation`	$201.00M	USD	1 Quarter
Depreciation	`Depreciation`	$203.00M	USD	1 Quarter
Depreciation	`Depreciation`	$407.00M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$1.80B	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$2.00B	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$4.01B	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$3.70B	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-119.00M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-794.00M	USD	2 Qtrs
Change in fair value of contingent consideration liabilities	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$861.00M	USD	2 Qtrs
Change in fair value of contingent consideration liabilities	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$2.35B	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$413.00M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$428.00M	USD	2 Qtrs
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$317.00M	USD	2 Qtrs
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$269.00M	USD	1 Quarter
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$414.00M	USD	2 Qtrs
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$132.00M	USD	1 Quarter
Gain on divestitures	`GainLossOnSaleOfOtherAssets`	$172.00M	USD	2 Qtrs
Gain on divestitures	`GainLossOnSaleOfOtherAssets`	$68.00M	USD	2 Qtrs
Non-cash litigation reserve adjustments, net of cash payments	`NonCashLitigationReserveAdjustmentsNetOfCashPayments`	$2.19B	USD	2 Qtrs
Non-cash litigation reserve adjustments, net of cash payments	`NonCashLitigationReserveAdjustmentsNetOfCashPayments`	$97.00M	USD	2 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$30.00M	USD	2 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$86.00M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.40B	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.16B	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$249.00M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$499.00M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-14.00M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$281.00M	USD	2 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-448.00M	USD	2 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$308.00M	USD	2 Qtrs
Income tax assets and liabilities, net	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$-110.00M	USD	2 Qtrs
Income tax assets and liabilities, net	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$-562.00M	USD	2 Qtrs
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$9.91B	USD	2 Qtrs
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$9.77B	USD	2 Qtrs
Acquisitions and investments	`PaymentsToAcquireOtherInvestments`	$394.00M	USD	2 Qtrs
Acquisitions and investments	`PaymentsToAcquireOtherInvestments`	$345.00M	USD	2 Qtrs
Acquisitions of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$305.00M	USD	2 Qtrs
Acquisitions of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$383.00M	USD	2 Qtrs
Purchases of investment securities	`PaymentsToAcquireMarketableSecurities`	$1.41B	USD	2 Qtrs
Purchases of investment securities	`PaymentsToAcquireMarketableSecurities`	$56.00M	USD	2 Qtrs
Sales and maturities of investment securities	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$65.00M	USD	2 Qtrs
Sales and maturities of investment securities	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$50.00M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-135.00M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-599.00M	USD	2 Qtrs
Cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.46B	USD	2 Qtrs
Cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-584.00M	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$2.00B	USD	2 Qtrs
Repayments of long-term debt and finance lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$3.46B	USD	2 Qtrs
Repayments of long-term debt and finance lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$4.88B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$5.03B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$4.63B	USD	2 Qtrs
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$1.48B	USD	2 Qtrs
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$797.00M	USD	2 Qtrs
Proceeds from the exercise of stock options	`ProceedsFromStockOptionsExercised`	$198.00M	USD	2 Qtrs
Proceeds from the exercise of stock options	`ProceedsFromStockOptionsExercised`	$144.00M	USD	2 Qtrs
Payments of contingent consideration liabilities	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$313.00M	USD	2 Qtrs
Payments of contingent consideration liabilities	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$482.00M	USD	2 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$1.00M	USD	2 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$26.00M	USD	2 Qtrs
Cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-9.06B	USD	2 Qtrs
Cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-9.65B	USD	2 Qtrs
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-28.00M	USD	2 Qtrs
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-26.00M	USD	2 Qtrs
Net change in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$97.00M	USD	2 Qtrs
Net change in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.23B	USD	2 Qtrs
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.75B	USD	Point-in-time
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.52B	USD	Point-in-time
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.55B	USD	Point-in-time
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.45B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.75B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.52B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.55B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.45B	USD	Point-in-time

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.10B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.73B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.69B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.59B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.44B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.31B	USD	Point-in-time
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$924.00M	USD	1 Quarter
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$766.00M	USD	1 Quarter
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$4.32B	USD	2 Qtrs
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$5.41B	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-212.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-297.00M	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$192.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$14.00M	USD	2 Qtrs
Dividends declared	`DividendsCommonStockCash`	$2.51B	USD	1 Quarter
Dividends declared	`DividendsCommonStockCash`	$4.63B	USD	2 Qtrs
Dividends declared	`DividendsCommonStockCash`	$2.32B	USD	1 Quarter
Dividends declared	`DividendsCommonStockCash`	$5.03B	USD	2 Qtrs
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$1.48B	USD	2 Qtrs
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$797.00M	USD	2 Qtrs
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$10.00M	USD	1 Quarter
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$9.00M	USD	1 Quarter
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$632.00M	USD	2 Qtrs
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$178.00M	USD	1 Quarter
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$591.00M	USD	2 Qtrs
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$229.00M	USD	1 Quarter
Change in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	$4.00M	USD	1 Quarter
Change in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	$7.00M	USD	2 Qtrs
Change in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	$2.00M	USD	1 Quarter
Change in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	$4.00M	USD	2 Qtrs
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.10B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.73B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.69B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.59B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.44B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.31B	USD	Point-in-time

Comprehensive Income 52 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$769.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$928.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$5.42B	USD	2 Qtrs
Net earnings	`ProfitLoss`	$4.32B	USD	2 Qtrs
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-19.00M	USD	2 Qtrs
Foreign currency translation adjustments, net of tax expense (benefit) of $(12) for the three months and $(19) for the six months ended June 30, 2022 and $1 for the three months and $(24) for the six months ended June 30, 2021	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-433.00M	USD	2 Qtrs
Foreign currency translation adjustments, net of tax expense (benefit) of $(12) for the three months and $(19) for the six months ended June 30, 2022 and $1 for the three months and $(24) for the six months ended June 30, 2021	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-823.00M	USD	1 Quarter
Foreign currency translation adjustments, net of tax expense (benefit) of $(12) for the three months and $(19) for the six months ended June 30, 2022 and $1 for the three months and $(24) for the six months ended June 30, 2021	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-1.05B	USD	2 Qtrs
Foreign currency translation adjustments, net of tax expense (benefit) of $(12) for the three months and $(19) for the six months ended June 30, 2022 and $1 for the three months and $(24) for the six months ended June 30, 2021	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$244.00M	USD	1 Quarter
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-12.00M	USD	1 Quarter
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-24.00M	USD	2 Qtrs
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$1.00M	USD	1 Quarter
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$-31.00M	USD	1 Quarter
Net investment hedging activities, net of tax expense (benefit) of $146 for the three months and $183 for the six months ended June 30, 2022 and $(31) for the three months and $72 for the six months ended June 30, 2021	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$666.00M	USD	2 Qtrs
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$72.00M	USD	2 Qtrs
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$183.00M	USD	2 Qtrs
Net investment hedging activities, net of tax expense (benefit) of $146 for the three months and $183 for the six months ended June 30, 2022 and $(31) for the three months and $72 for the six months ended June 30, 2021	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$536.00M	USD	1 Quarter
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$146.00M	USD	1 Quarter
Net investment hedging activities, net of tax expense (benefit) of $146 for the three months and $183 for the six months ended June 30, 2022 and $(31) for the three months and $72 for the six months ended June 30, 2021	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$-114.00M	USD	1 Quarter
Net investment hedging activities, net of tax expense (benefit) of $146 for the three months and $183 for the six months ended June 30, 2022 and $(31) for the three months and $72 for the six months ended June 30, 2021	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$260.00M	USD	2 Qtrs
Pension and post-employment benefits, net of tax expense (benefit) of $11 for the three months and $21 for the six months ended June 30, 2022 and $14 for the three months and $33 for the six months ended June 30, 2021	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-48.00M	USD	1 Quarter
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-21.00M	USD	2 Qtrs
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-14.00M	USD	1 Quarter
Pension and post-employment benefits, net of tax expense (benefit) of $11 for the three months and $21 for the six months ended June 30, 2022 and $14 for the three months and $33 for the six months ended June 30, 2021	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-129.00M	USD	2 Qtrs
Pension and post-employment benefits, net of tax expense (benefit) of $11 for the three months and $21 for the six months ended June 30, 2022 and $14 for the three months and $33 for the six months ended June 30, 2021	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-76.00M	USD	2 Qtrs
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-11.00M	USD	1 Quarter
Pension and post-employment benefits, net of tax expense (benefit) of $11 for the three months and $21 for the six months ended June 30, 2022 and $14 for the three months and $33 for the six months ended June 30, 2021	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-50.00M	USD	1 Quarter
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-33.00M	USD	2 Qtrs
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$3.00M	USD	2 Qtrs
Cash flow hedging activities, net of tax expense (benefit) of $5 for the three months and $3 for the six months ended June 30, 2022 and $ for the three months and $3 for the six months ended June 30, 2021	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$15.00M	USD	2 Qtrs
Cash flow hedging activities, net of tax expense (benefit) of $5 for the three months and $3 for the six months ended June 30, 2022 and $ for the three months and $3 for the six months ended June 30, 2021	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$12.00M	USD	1 Quarter
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$5.00M	USD	1 Quarter
Cash flow hedging activities, net of tax expense (benefit) of $5 for the three months and $3 for the six months ended June 30, 2022 and $ for the three months and $3 for the six months ended June 30, 2021	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$27.00M	USD	1 Quarter
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$3.00M	USD	2 Qtrs
Cash flow hedging activities, net of tax expense (benefit) of $5 for the three months and $3 for the six months ended June 30, 2022 and $ for the three months and $3 for the six months ended June 30, 2021	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$58.00M	USD	2 Qtrs
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	-	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-212.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-297.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$192.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$14.00M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$4.34B	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$716.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.12B	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$961.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$3.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$7.00M	USD	2 Qtrs
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$4.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$5.00M	USD	2 Qtrs
Comprehensive income attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$958.00M	USD	1 Quarter
Comprehensive income attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$5.12B	USD	2 Qtrs
Comprehensive income attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$4.33B	USD	2 Qtrs
Comprehensive income attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$712.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.